Trials / Completed
CompletedNCT05328986
Kidney Disease After COVID-19
Multi-center Assessment of Survivors for Kidney Disease After COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,753 (actual)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To understand the long-term epidemiology, develop effective risk-prediction and stratification tools, and understand the pathobiology of kidney disease in COVID-19 survivors.
Conditions
Timeline
- Start date
- 2020-01-04
- Primary completion
- 2024-01-04
- Completion
- 2024-01-04
- First posted
- 2022-04-14
- Last updated
- 2025-07-20
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05328986. Inclusion in this directory is not an endorsement.